Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) Bundle
From its founding in 1991 to serving clinicians across over 190 countries, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. has grown into a global force with more than 21,000 employees, a clear mission to "advance medical technologies to make healthcare more accessible," and a vision of "better healthcare for all" that drives product lines from patient monitors to total laboratory automation; the company channels roughly 10% of revenue into R&D and reported revenues of USD 3.63 billion (up 11.4%) in 2022, illustrating how its core values-aligning with customers, valuing and enriching people, being precise and practical, and always forging ahead-translate into measurable scale, innovation investment, and global reach that reshape accessibility and affordability in modern healthcare, inviting you to explore how those strategic pillars power real-world clinical impact.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) - Intro
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ), founded in 1991 and headquartered in Shenzhen, China, is a leading global provider of medical devices and integrated clinical solutions. Mindray's core business spans patient monitoring & life support, in‑vitro diagnostics (IVD), and medical imaging, with products deployed in hospitals, clinics and laboratories across more than 190 countries.- Founded: 1991
- Headquarters: Shenzhen, China
- Global footprint: operates in >190 countries
- Employees: >21,000 globally
- Stock: Shenzhen Stock Exchange - 300760.SZ
| Metric | Value (2022) |
|---|---|
| Revenue | USD 3.63 billion |
| Year-on-Year Revenue Growth | +11.4% |
| R&D Spend (% of Revenue) | ~10% |
| Approx. R&D Investment | ~USD 363 million |
| Employees | >21,000 |
| Market Presence | >190 countries |
- To advance healthcare and improve lives by providing accessible, high‑quality medical technologies and solutions worldwide.
- To empower clinicians with reliable, affordable, and easy‑to‑use equipment across the continuum of care.
- To become the trusted global partner for medical technology, driving better patient outcomes through continuous innovation and systemic clinical solutions.
- To expand access to modern healthcare by integrating digital, AI‑enabled, and connected devices into clinical workflows.
- Innovation - sustained investment in R&D (approx. 10% of revenue) to deliver clinically relevant advances.
- Quality & Safety - adherence to international quality standards to ensure patient safety and product reliability.
- Customer Focus - designing solutions that meet diverse clinical needs from point‑of‑care to centralized labs.
- Global Collaboration - building partnerships with healthcare providers, distributors, and research institutions worldwide.
- Integrity & Responsibility - ethical conduct, regulatory compliance, and commitment to social responsibility.
- Patient monitoring & life support: multi‑parameter monitors, ventilators, anesthesia systems.
- In‑vitro diagnostics (IVD): hematology, chemistry, immunoassay systems, and total laboratory automation.
- Medical imaging: ultrasound platforms covering general imaging, cardiovascular, and point‑of‑care ultrasound.
- Services & digital: lifecycle services, AI‑enabled analytics, connectivity and clinical workflow integration.
- Significant R&D allocation (~USD 363M in 2022) to sustain product pipeline and platform upgrades.
- Balanced global expansion: deepening presence in emerging markets while growing share in advanced healthcare systems.
- Portfolio breadth to serve acute care, ambulatory, and laboratory settings-reducing revenue concentration risk.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) - Overview
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) anchors its corporate identity around a clear mission: to advance medical technologies to make healthcare more accessible. This mission shapes product strategy, global expansion, and day-to-day decision-making, emphasizing usability, reliability, rapid response to clinical needs, and humanity-centered care.- Mission focus: develop reliable, easy-to-use clinical solutions that let healthcare professionals prioritize patient care.
- Clinical collaboration: ongoing partnerships with hospitals, clinicians, and research institutions to translate frontline needs into product features and iterative improvements.
- Technology adoption: accelerate and adapt core medical technologies (e.g., patient monitoring, in vitro diagnostics, ultrasound) to accessible, market-ready products.
- Humanity in healthcare: align technological advances with patient-centric workflows and affordability considerations.
| Indicator | Value | Notes / Year |
|---|---|---|
| Revenue | RMB 31.62 billion | FY2023 |
| Net profit (attributable) | RMB 5.71 billion | FY2023 |
| R&D expenditure | RMB 3.6 billion | FY2023 (~11.4% of revenue) |
| Employees | ~18,000 | Global headcount, 2023 |
| Global presence | 190+ countries & regions | Commercial footprint |
| Export / Overseas revenue share | ~70% | FY2023 estimate |
- Product portfolio alignment - prioritizing monitoring, ultrasound, and diagnostics that address high-burden conditions and resource-limited settings.
- R&D intensity - sustained double-digit percentage of revenue allocated to innovation, supporting faster product cycles and regulatory approvals globally.
- Manufacturing scalability - investments in automated production and quality systems to ensure consistent supply and cost control for global markets.
- Market responsiveness - ability to tailor products and service models regionally based on clinician input and epidemiological trends.
- Clinical partnerships: dozens of large hospital collaborations and multi-center trials annually to validate product efficacy and inform iteration.
- After-sales network: extensive local service and training teams across major markets to maximize device uptime and clinician adoption.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) - Mission Statement
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) centers its mission and strategic intent around a compact, human-focused credo: expand access to high-quality, affordable healthcare while respecting every life. This mission is the operational backbone that channels R&D, manufacturing scale, market deployment, and corporate governance toward tangible impact in clinical environments worldwide.- Core mission: deliver clinically relevant medical devices and solutions that improve patient outcomes while lowering the total cost of care.
- Patient-centered focus: prioritize safety, usability, and clinical efficacy in product design to give every life respect.
- Affordability mandate: drive cost-efficient engineering, localised manufacturing, and scale effects to broaden access in emerging and developed markets alike.
- Global reach with local relevance: adapt solutions to health systems across geographies to address aging populations, rising costs, and fragmented care pathways.
- Address aging populations: portfolio emphasis on point-of-care diagnostics, patient monitoring, and critical care solutions that support geriatric and chronic-care workflows.
- Combat rising costs: product lines and service models designed to reduce total cost of ownership for hospitals and clinics.
- Promote integrated care: focus on interoperable platforms and data-driven workflows to connect diagnostics, monitoring, and therapy.
- Human-centered innovation: design and delivery choices that reflect respect for patients and frontline clinicians.
| Metric | Data / Figure |
|---|---|
| Global footprint | Products sold in 190+ countries and regions |
| Healthcare customers | Used by tens of thousands of hospitals and clinical sites worldwide |
| Employees (approx.) | ~16,000-17,000 global staff (R&D, manufacturing, sales, service) |
| R&D intensity | R&D investment typically ~8-11% of annual revenue (multi-year average) |
| Product scope | Clinical laboratories, patient monitoring & life support, medical imaging, point-of-care diagnostics |
| Manufacturing scale | Multiple global manufacturing and R&D centers enabling cost-effective volume production and localization |
- Sustain R&D investment to keep product pipelines aligned with clinical needs and regulatory standards.
- Scale cost-efficiencies to reduce price barriers while preserving clinical performance.
- Expand ecosystem partnerships to integrate devices, software, and services for seamless care pathways.
- Ensure quality and regulatory compliance globally to maintain clinician trust and patient safety.
- Respect for life - decisions prioritize patient safety and dignity.
- Clinical relevance - products must demonstrably improve diagnosis, monitoring, or therapy.
- Accessibility - affordability and distribution strategies to broaden access.
- Accountability - quality systems, post-market surveillance, and transparent governance.
- Continuous improvement - iterative innovation and data-driven optimization.
| Area | How it supports the mission |
|---|---|
| R&D spend | Funds innovation to produce clinically impactful, affordable devices |
| Manufacturing scale | Enables lower unit cost and faster localization to serve diverse markets |
| Service & distribution network | Ensures uptime and access in resource-constrained settings |
| Regulatory compliance | Builds clinician and patient trust essential for broad adoption |
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) - Vision Statement
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) envisions becoming a globally trusted provider of medical devices and solutions that enable accessible, high-quality healthcare. The vision emphasizes integrated patient-centered systems, broad global reach, and sustained technology leadership to support hospitals, clinics, and care providers across acute care, life support, and diagnostic segments. Core Values- Aligning with customers - deeply understanding clinical workflows, priorities, and constraints to deliver solutions that meet real-world needs and improve patient outcomes.
- Valuing and enriching people - investing in employees' growth, skills, and well‑being; recognizing contributions that drive the company forward.
- Being precise and practical - designing reliable, easy-to-use products and services that improve operational efficiency and clinical decision-making.
- Always forging ahead - committing to continuous innovation, adopting emerging technologies (AI, digital platforms, connected devices), and adapting to evolving healthcare delivery models.
| Metric | Value (approx.) | Notes |
|---|---|---|
| Annual revenue | RMB 40-46 billion (FY2023, approx.) | Reflects sales across Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging |
| Net profit (attributable) | RMB 6-8 billion (FY2023, approx.) | Profitability supported by product mix and operational efficiencies |
| R&D expenditure | RMB 4-5 billion (FY2023, approx.) | Represents roughly 10-12% of revenue, underlining commitment to innovation |
| R&D headcount | ~7,000 (approx.) | Substantial in-house engineering and clinical research teams across global sites |
| Employees (total) | ~15,000-17,000 (approx.) | Global footprint including manufacturing, sales, and service personnel |
| International revenue share | ~40-60% (varies by year) | Significant export footprint spanning 190+ countries and regions |
| Installed base (devices & systems) | Millions of units globally (approx.) | Large installed base drives recurring service and consumables revenue |
- Customer alignment informs product roadmaps: clinical feedback loops and hospital partnerships accelerate feature prioritization and deployment.
- People-first culture drives talent retention and capability building: training, internal mobility, and performance recognition support sustained execution.
- Precision and practicality shape product design: emphasis on usability, uptime, maintenance simplicity, and regulatory compliance across major markets.
- Forward momentum channels capital into R&D and strategic M&A: resources allocated to AI, digital health platforms, and expanded point‑of‑care diagnostics.
- High R&D intensity (double‑digit % of revenue) sustaining a product pipeline that supports mid‑to‑long term growth.
- Strong installed base and service network enabling recurring revenue and favourable gross margin dynamics.
- Broad international presence reducing geographic concentration risk and supporting scale economies.
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (300760.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.